Lovastatin/SN38 co-loaded liposomes amplified ICB therapeutic effect via remodeling the immunologically-cold colon tumor and synergized stimulation of cGAS-STING pathway
Cancer Letters · 2024
DOI: 10.1016/j.canlet.2024.216765 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Letters, 2024. Verfasst von Yi Yang und 12 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Science, State Key Laboratory of Respiratory Disease & The Second Affiliated Hospital, Guangzhou Medical University, Guangzh…. Hauptthemen laut MEDLINE: Colonic Neoplasms, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Neoplasms. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: Guangzhou Municipal Science and Technology Bureau, Guangzhou Medical University, State Key Laboratory of Respiratory Disease.
Abstract (Originalsprache)
Current immune checkpoint blockade (ICB) immunotherapeutics have revolutionized cancer treatment. However, many cancers especially the "immunologically cold" tumors, do not respond to ICB, prompting the search for additional strategies to achieve durable responses. The cGAS-STING pathway, as an essential immune response pathway, has been demonstrated for a potent target to sensitize ICB immunotherapy. However, the low efficiency of conventional STING agonists limits their clinical application. Recent studies have shown that DNA topoisomerase I (TOPI) inhibitor chemodrug SN38 can activate the cGAS-STING pathway and induce an immune response through DNA damage, while the traditional statins medication lovastatin was found to inhibit DNA damage repair, which may in turn upregulate the damaged DNA level. Herein, we have developed a liposomal carrier co-loaded with SN38 and lovastatin (SL@Lip), which can be accumulated in tumors and efficiently released SN38 and lovastatin, addressing the problem of weak solubility of these two drugs. Importantly, lovastatin can increase DNA damage and enhance the activation of cGAS-STING pathway, coordinating with SN38 chemotherapy and exhibiting the enhanced combinational immunotherapy of PD-1 antibody by remodeling the tumor microenvironment in mouse colorectal cancer of both subcutaneous and orthotopic xenograft models. Overall, this study demonstrates that lovastatin-assisted cGAS-STING stimulation mediated by liposomal delivery system significantly strengthened both chemotherapy and immunotherapy of colorectal cancer, providing a clinically translational strategy for combinational ICB therapy in the "immunologically cold" tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmaceutical Science, State Key Laboratory of Respiratory Disease & The Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, 511436, PR China.
- Yunnan Digestive Endoscopy Clinical Medical Center, Department of Gastroenterology, The First People's Hospital of Yunnan Province, Kunming, 650032, PR China.
- School of Pharmaceutical Science, State Key Laboratory of Respiratory Disease & The Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, 511436, PR China. Electronic address: xcshan@163.com.
- School of Biomedical Engineering, University of Technology Sydney, Ultimo, NSW, 2007, Australia. Electronic address: Wei.Deng@uts.edu.au.
- School of Pharmaceutical Science, State Key Laboratory of Respiratory Disease & The Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, 511436, PR China. Electronic address: wenjie.chen1@hdr.mq.edu.au.
Förderung
- Guangzhou Municipal Science and Technology Bureau
- Guangzhou Medical University
- State Key Laboratory of Respiratory Disease
Zitieren
APA
Yang, Y., Qi, J., Hu, J., Zhou, Y., Zheng, J., Deng, W., Inam, M., Guo, J., Xie, Y., Li, Y., Xu, C., Deng, W., & Chen, W. (2024). Lovastatin/SN38 co-loaded liposomes amplified ICB therapeutic effect via remodeling the immunologically-cold colon tumor and synergized stimulation of cGAS-STING pathway. Cancer Letters. https://doi.org/10.1016/j.canlet.2024.216765
Vancouver
Yang Y, Qi J, Hu J, Zhou Y, Zheng J, Deng W, et al. Lovastatin/SN38 co-loaded liposomes amplified ICB therapeutic effect via remodeling the immunologically-cold colon tumor and synergized stimulation of cGAS-STING pathway. Cancer Letters. 2024. doi:10.1016/j.canlet.2024.216765
BibTeX
@article{Yang2024,
author = {Yang, Yi and Qi, Jialong and Hu, Jialin and Zhou, You and Zheng, Jiena and Deng, Wenxia and Inam, Muhammad and Guo, Jiaxin and Xie, Yongyi and Li, Yuan and Xu, Chuanshan and Deng, Wei and Chen, Wenjie},
title = {Lovastatin/SN38 co-loaded liposomes amplified ICB therapeutic effect via remodeling the immunologically-cold colon tumor and synergized stimulation of cGAS-STING pathway},
journal = {Cancer Letters},
year = {2024},
doi = {10.1016/j.canlet.2024.216765}
}
EUVIMED